Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer
SUZHOU, China, March 24, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in the Phase III clinical study (KN026-007) of HER2 bispecific antibody Anbenitamab (KN026) in combination...
Hollywood-Bound: Local Family-Owned Wellness Brand Takes Centre Stage in Hollywood's Coveted Mother's Day Gift Bag
GOLD COAST, Australia, May 28, 2025 /PRNewswire/ -- Australian family-owned and operated, Biosota Organics has officially gone Hollywood. The brand's award-winning high MGO-rated Manuka honey was featured in the highly anticipated 2025 Hollywood...